Accumulated studies have shown that Dab2 is reduced or lost in human cancers, containing lung cancers, nasopharyngeal carcinomas, the breast cancers, and colorectal cancers, et al.12-19 Thus, it is gradually considered as a tumor suppressor gene. Here, DAB2 is linked to nasopharyngeal carcinoma.